Collection of Post-treatment PRO Data in Oncology Clinical Trials

As patient-reported outcome (PRO) measures are being included more frequently in oncology clinical trials, regulatory and health technology assessment agencies have begun to request long-term, post-treatment PRO data to supplement traditional survival/progression endpoints. These data may be collect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundy, J. Jason, Coon, Cheryl D., Fu, An-Chen, Pawar, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785546/
https://www.ncbi.nlm.nih.gov/pubmed/32643079
http://dx.doi.org/10.1007/s43441-020-00195-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785546/
https://www.ncbi.nlm.nih.gov/pubmed/32643079
http://dx.doi.org/10.1007/s43441-020-00195-3

Ejemplares similares